These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19833205)

  • 21. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
    Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
    Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to berberine.
    Wen CJ; Wu LX; Fu LJ; Shen DY; Zhang X; Zhang YW; Yu J; Zhou HH
    Asian Pac J Cancer Prev; 2014; 15(1):495-9. PubMed ID: 24528081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells.
    Wang H; Leung LK
    Nutrition; 2010; 26(11-12):1181-7. PubMed ID: 20400267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1.
    Pang S; Cao JQ; Katz BH; Hayes CL; Sutter TR; Spink DC
    Biochem Pharmacol; 1999 Jul; 58(1):29-38. PubMed ID: 10403516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogens, enzyme variants, and breast cancer: a risk model.
    Crooke PS; Ritchie MD; Hachey DL; Dawling S; Roodi N; Parl FF
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1620-9. PubMed ID: 16985022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol.
    Li DN; Seidel A; Pritchard MP; Wolf CR; Friedberg T
    Pharmacogenetics; 2000 Jun; 10(4):343-53. PubMed ID: 10862525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
    Lee AJ; Cai MX; Thomas PE; Conney AH; Zhu BT
    Endocrinology; 2003 Aug; 144(8):3382-98. PubMed ID: 12865317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
    Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
    Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
    Dubey RK; Gillespie DG; Zacharia LC; Barchiesi F; Imthurn B; Jackson EK
    Hypertension; 2003 Mar; 41(3 Pt 2):807-13. PubMed ID: 12624000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
    Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
    Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.
    Hachey DL; Dawling S; Roodi N; Parl FF
    Cancer Res; 2003 Dec; 63(23):8492-9. PubMed ID: 14679015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1.
    Spink DC; Spink BC; Zhuo X; Hussain MM; Gierthy JF; Ding X
    J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):11-8. PubMed ID: 11074351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
    Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
    Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
    Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
    Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
    Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.